CRP and breast carcinoma: This study also assessed the correlation between hepcidin levels and a commonly used breast cancer biomarker, the cancer antigen 15‐3 (CA15‐3), and one of the potential regulators of hepcidin in cancers, the C‐reactive protein (CRP).